HC Wainwright Issues Optimistic Estimate for AKRO Earnings
Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) – Equities research analysts at HC Wainwright lifted their Q1 2025 EPS estimates for Akero Therapeutics in a research note issued to investors on Monday, March 3rd. HC Wainwright analyst E. Arce now forecasts that the company will post earnings of ($0.96) per share for the quarter, up […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) – Equities research analysts at HC Wainwright lifted their Q1 2025 EPS estimates for Akero Therapeutics in a research note issued to investors on Monday, March 3rd. HC Wainwright analyst E. Arce now forecasts that the company will post earnings of ($0.96) per share for the quarter, up […]
